REFERENCES
- Matheson, B., Raznaka, A., Kwansa, H., Bucci, E. (2002). Vascular response to infusions of a nonextravasating hemoglobin polymer. Journal of Applied Physiology 93: 1479–1486. [INFOTRIEVE], [CSA]
- Niiler, E. (2002). Setbacks for blood substitute companies. Nature Biotechnology 20: 962–963. [INFOTRIEVE], [CSA], [CROSSREF]
- Chang, T.M.S. (2003). Future generations of red blood cell substitutes. Journal of Internal Medicine 253: 527–535. [INFOTRIEVE], [CSA], [CROSSREF]
- Chang, T.M.S. (2004). Hemoglobin-based red blood cell substitutes. Artificial Organs 28: 789–794. [INFOTRIEVE], [CSA], [CROSSREF]
- Chang, T.M.S. (2005). Therapeutic applications of polymeric artificial cells. Nature Reviews Drug Discovery 4: 221–235. [INFOTRIEVE], [CSA], [CROSSREF]
- Lowe, K.C. (2003). Engineering blood: synthetic substitutes from fluorinated compounds. Tissue Engineering 9: 389–399. [INFOTRIEVE], [CSA], [CROSSREF]
- Lowe, K.C. (2004). Blood substitutes. Education in Chemistry 41: 95–97. [CSA]
- Vandegriff, K.D., Malavalli, A., Woodridge, J., Lohman, J., Winslow, R. (2003). MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43: 509–516. [INFOTRIEVE], [CSA], [CROSSREF]
- Winslow, R.M. (2003). Current status of blood substitute research: towards a new paradigm. Journal of Internal Medicine 253: 508–517. [INFOTRIEVE], [CSA], [CROSSREF]
- Alayash, A.I. (2004). Oxygen therapeutics: can we tame haemoglobin? Nature Reviews 3: 152–159. [INFOTRIEVE], [CSA], [CROSSREF]
- Buehler, P.W., Alayash, A.I. (2004). Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Transfusion 44: 1516–1530. [INFOTRIEVE], [CSA], [CROSSREF]
- Zuckerman, S.H., Doyle, M.P., Gorczynski, R., Rosenthal, G.J. (1998). Preclinical biology of recombinant human hemoglobin, rHB1.1. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 26: 231–257. [INFOTRIEVE], [CSA]
- Dieryck, W., Grüber, V., Baudino, S., Lenee, P., Pagnier, J., Mérot, B., Poyart, C. (1995). Recombinant protein expression in plants. Transfusion Clinique et Biologique 2: 441–447. [INFOTRIEVE], [CSA], [CROSSREF]
- Dieryck, W., Pagnier, J., Poyart, C., Marden, M.C., Grüber, V., Bournat, P., Baudino, S., Mérot, B. (1997). Human haemoglobin from transgenic tobacco. Nature 386: 29–30. [INFOTRIEVE], [CSA], [CROSSREF]
- Galun, E., Galun, E. (2001). The Manufacture of Medicinal and Health Products by Transgenic Plants, Imperial College Press: London, pp. 332.
- Olsen, J., Foley, E.W., Rogge, C., Tsai, A.-L., Doyle, M.P., Lemon, D.D. (2004). NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radical Biology and Medicine 36: 685–697. [CSA], [CROSSREF]
- Finucane, M., Slovic, P., Mertz, C. (2000). Public perception of the risk of blood transfusion. Transfusion 40: 1017–1022. [INFOTRIEVE], [CSA], [CROSSREF]
- Ferguson, E.M.P., Farrell, K., Lowe, K.C., James, V. (2001). Perception of risk of blood transfusion: knowledge, group membership and perceived control. Transfusion Medicine 11: 129–135. [INFOTRIEVE], [CSA], [CROSSREF]
- Lowe, K.C., Farrell, K., Ferguson, E.M.P., James, V. (2001). Current perceived risks of transfusion in the UK and relevance to the future acceptance of blood substitutes. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 29: 179–189. [INFOTRIEVE], [CSA], [CROSSREF]
- Lowe, K.C., Ferguson, E. (2003). Benefit and risk perceptions in transfusion medicine: blood and blood substitutes. Journal of Internal Medicine 253: 498–507. [INFOTRIEVE], [CSA], [CROSSREF]
- Ferguson, E., Farrell, K., James, V., Lowe, K.C. (2004). Trustworthiness of information about blood donation and transfusion in relation to knowledge and perceptions of risk: an analysis of UK stakeholder groups. Transfusion Medicine 14: 205–216. [INFOTRIEVE], [CSA], [CROSSREF]
- Moxey, A.J., O'Connell, D.L., Treloar, C.J., Han, P.Y.S., Henry, D.A. (2005). Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members and the public. Transfusion Medicine 15: 19–32. [INFOTRIEVE], [CSA], [CROSSREF]
- Hill, J., James, V. (2003). Survey of autologous blood transfusion activity in England (2001). Transfusion Medicine 13: 9–15. [INFOTRIEVE], [CSA], [CROSSREF]
- Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, L., Snider, C., Fink, A., Brook, R. (2005). The cost effectiveness of autologous blood donations. New England Journal of Medicine 332: 719–724. [CSA], [CROSSREF]
- Lee, D.H., Mehta, M.D. (2003). Evaluation of a visual risk communication tool: effects on knowledge and perception of blood transfusion risk. Transfusion 43: 779–787. [INFOTRIEVE], [CSA], [CROSSREF]
- Rock, G., Berger, R., Pinkerton, P., Fernandes, B. (2002). A pilot study to assess physician knowledge in transfusion medicine. Transfusion Medicine 12: 125–128. [INFOTRIEVE], [CSA], [CROSSREF]
- Farrell, K., Ferguson, E.M.P., James, V., Lowe, K.C. (2001). Confidence in the safety of blood for transfusion: the effect of message framing. Transfusion 41: 1335–1340. [INFOTRIEVE], [CSA], [CROSSREF]
- Farrell, K., Ferguson, E.M.P., James, V., Lowe, K.C. (2002). Public perception of the risk of HIV infection associated with blood donation: the role of contextual clues. Transfusion 42: 679–683. [INFOTRIEVE], [CSA], [CROSSREF]
- Grant, F.C., Laupacis, A., O'Connor, A.M., Rubens, F., Robblee, J. (2001). Evaluation of a decision aid for patients considering autologous blood donation before open-heart surgery. Canadian Medical Association Journal 164: 1139–1144. [INFOTRIEVE], [CSA]
- Lee, D.H., Mehta, M.D., James, P.D. (2003) Differences in the perception of blood transfusion risk between laypeople. Transfusion 43: 772–778. [INFOTRIEVE], [CSA], [CROSSREF]
- Hessel, E. (2005). Dracula. Forbes Global 6 June 2005: 60–61. [CSA]